索格列净
Tier C — Watch / tradeSotagliflozin · all drugs expiring in 2032 →
Targets：SGLT2、SGLT1
Brand：INPEFA、Zynquista
Indications (approved)：二型糖尿病、慢性肾功能不全、心脏衰竭
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| SOTA-001 | 7296-58-4Available | (3S,4R,5S)-tetrahydro-2H-pyran-2,3,4,5-tetraol |
| SOTA-002 | 114861-22-2Available | (3aS,5S,6R,6aS)-5-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol |
| SOTA-003 | 1103738-17-5Available | (3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid |
| SOTA-004 | 110-91-8Available | morpholine |
| SOTA-005 | 1103738-19-7Available | ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone |
| SOTA-006 | 1103738-29-9Available | 1-chloro-2-(4-ethoxybenzyl)-4-iodobenzene |
| SOTA-007 | 1103738-30-2Available | (4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone |
| SOTA-008 | 1384242-55-0Available | (2S,3S,4R,5R,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetraol |
| SOTA-009 | 1384242-56-1Available | (2R,3S,4R,5S,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate |
| SOTA-010 | 1018899-03-0Available | (2S,3S,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
| SOTA-011 | 19094-56-5Available | 2-chloro-5-iodobenzoic acid |
| SOTA-012 | 281652-58-2Available | 2-chloro-5-iodobenzoyl chloride |
| SOTA-013 | 103-73-1Available | ethoxybenzene |
| SOTA-014 | 1103738-26-6Available | (2-chloro-5-iodophenyl)(4-ethoxyphenyl)methanone |
Frequently asked questions
What are the approved indications of Sotagliflozin?
Approved indications include: 二型糖尿病, 慢性肾功能不全, 心脏衰竭.
When does the Sotagliflozin patent expire?
Based on public sources, the Sotagliflozin patent expires in 2032.
How many synthesis routes are recorded for Sotagliflozin?
1 synthesis routes are recorded; the shortest is 11 steps with 67.00 g (Sotagliflozin) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Sotagliflozin intermediates?
14 intermediate CAS of Sotagliflozin are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Sotagliflozin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24